Novateor Research Laboratories Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
- Paid Up Capital ₹ 4.83 Cr
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.12 Cr
- Satisfied Charges ₹ 1.44 Cr
- Revenue Growth 94.08%
- Profit Growth -2035.33%
- Ebitda 43.72%
- Net Worth -8.53%
- Total Assets -9.27%
About Novateor Research Laboratories
Novateor Research Laboratories Limited (NRLL) is a Public Limited Indian Non-Government Company incorporated in India on 01 April 2011 and has a history of 13 years and ten months. Its registered office is in Ahmedabad, Gujarat, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 542771.
The Corporate was formerly known as Novateor Research Laboratories Private Limited. The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 4.83 Cr.
The company currently has active open charges totaling ₹3.12 Cr. The company has closed loans amounting to ₹1.44 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Novateor Research Laboratories Limited India are Nitinkumar Shah as COMPANY SECRETARY and Navdeep Mehta as Cfo. Navdeep Mehta, Jitin Doshi, Bhavya Doshi, and Three other members serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
L24230GJ2011PLC064731
-
Company No.
064731
-
Stock Symbol
BSE : 542771
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
01 Apr 2011
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Listed
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Novateor Research Laboratories Limited offer?
Novateor Research Laboratories Limited offers a wide range of products and services, including Dentist Tools, Equipment & Supplies, Dental Equipment.
Who are the key members and board of directors at Novateor Research Laboratories?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Navdeep Mehta
![]() |
Managing Director | 01-Apr-2011 | Current |
Nitinkumar Shah
![]() |
Company Secretary | 25-Sep-2024 | Current |
Board Members (5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jitin Doshi
![]() |
Director | 01-Sep-2022 | Current |
Bhavya Doshi
![]() |
Director | 26-Aug-2023 | Current |
Imran Khan
![]() |
Director | 29-Aug-2024 | Current |
Hiral Bane
![]() |
Director | 29-Aug-2024 | Current |
Tejal Mehta
![]() |
Whole-Time Director | 01-Apr-2011 | Current |
Financial Performance of Novateor Research Laboratories.
Novateor Research Laboratories Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 94.08% increase. The company also saw a substantial fall in profitability, with a 2035.33% decrease in profit. The company's net worth dipped by a decrease of 8.53%.
![Graph illustrating revenue growth over time](/Images/financial/revenue-growth.webp)
![Graph showing profit and loss trends over time](/Images/financial/profit-loss.webp)
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Novateor Research Laboratories?
In 2022, Novateor Research Laboratories had a promoter holding of 60.87% and a public holding of 39.13%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
![Shareholding Indicator graph](/Images/tcc-login/Shareholding-Indiacator-1200.webp)
Charges (Loans)
₹3.12 Cr
₹1.44 Cr
Charges Breakdown by Lending Institutions
- The Kalupur Commercial Co-Operative Bank Limited : 3.12 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
25 Jan 2023 | The Kalupur Commercial Co-Operative Bank Limited | ₹1.96 Cr | Open |
25 Jan 2023 | The Kalupur Commercial Co-Operative Bank Limited | ₹1.16 Cr | Open |
31 Aug 2016 | Others | ₹3.80 M | Satisfied |
27 Aug 2012 | The Cosmos Co-Operative Bank Ltd. | ₹1.06 Cr | Satisfied |
How Many Employees Work at Novateor Research Laboratories?
Unlock and access historical data on people associated with Novateor Research Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
![Graph showing employee growth trends](/Images/tcc-login/Employee-Graph.webp)
Deals i
![Graph showing company valuation over time](/Images/tcc-login/Valuation-Graph-small.webp)
Gain comprehensive insights into the Deals and Valuation data of Novateor Research Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novateor Research Laboratories's trajectory.
Rating
![Graph displaying rating trends over time](/Images/tcc-login/Rating-Graph-small.webp)
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
![Alert Indicator](/Images/tcc-login/Alert-Indicator-small.webp)
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.